Search clinical trials for: seasonal allergic rhinitis (SAR),

Total 4971 results

Ligand Pharmaceuticals

Completed

Compare CE-Budesonide Nasal Solution & Rhinocort Aqua in an EEC Study of AR

Seasonal Allergic Rhinitis

Canada
Glenmark Pharmaceuticals Ltd. India

Completed

Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR) (GSP 301- PoC)

Seasonal Allergic Rhinitis

Canada
Sunovion

Completed

Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Cosmetique Active International

Completed

DERCOS DS DANDRUFF TREATMENT OBSERVATIONAL STUDY 2022

Dandruff

Poland
Clarity Pharmaceuticals Ltd

Recruiting

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE) (SECuRE)

Prostatic Neoplasms, Castration-Resistant

United States
Aleksandra Novakov Mikic

Completed

Safety and Efficacy of Non-ablative Er:YAG Laser Therapy for the Treatment of Pelvic Organ Prolapse and Coexisting Stress Urinary Incontinence: A Retrospective Case Series.

Pelvic Organ Prolapse | Stress Urinary Incontinence | Cystocele

Serbia
Magna Pharmaceuticals, Inc.

Completed

Clinical Trial of STAHIST in Seasonal Allergic Rhinitis (SAR) Subjects (STA-2)

Seasonal Allergic Rhinitis

United States
Clarity Pharmaceuticals Ltd

Recruiting

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy (CLARIFY)

Prostatic Neoplasms | Prostate Cancer

United States
Clarity Pharmaceuticals Ltd

Active, not recruiting

64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE) (SABRE)

Biochemical Recurrence of Malignant Neoplasm of Prostate

United States
Shire

Completed

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye

Dry Eye Disease

United States
University of East Anglia
Norfolk and Norwich University Hospitals NHS Foundation Trust; Quadram Institute... and other collaborators

Completed

Seasonal Allergic Rhinitis Study (SAR)

Asthma | Grass Allergy | Seasonal Affective Rhinitis

United Kingdom
Magna Pharmaceuticals, Inc.

Completed

Trial of STAHIST in Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Clarity Pharmaceuticals Ltd

Completed

64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA) (COBRA)

Biochemical Recurrence of Malignant Neoplasm of Prostate

United States
Clarity Pharmaceuticals Ltd

Completed

Positron Emission Tomography (PET) Imaging of Participants With Confirmed Prostate Cancer Using 64Cu-SAR-bisPSMA (PROPELLER) (PROPELLER)

Prostatic Neoplasms

Australia
University of Michigan
American Lung Association

Active, not recruiting

Self-regulation for Older Adults With Asthma Through Remote Education (SOAR)

Asthma

United States
Clarity Pharmaceuticals Ltd

Recruiting

64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT) (COMBAT)

Prostatic Neoplasms | Castration-Resistant

United States
Evolutec Group

Unknown

Safety and Efficacy Study of rEV131 in Allergic Rhinitis

Hay Fever

United States
Johns Hopkins University
SARcode Bioscience

Terminated

SAR 1118 in Human Subjects Undergoing Pars Plana Vitrectomy

Pars Plana Vitrectomy | Diabetic Macular Edema (DME)

United States
Luke Nordquist, MD
Clarity Pharmaceuticals

Not yet recruiting

64Cu-SAR-bisPSMA Positron Emission Tomography of Patients With Known or Suspected Prostate Cancer

Prostate Cancer

United States
AstraZeneca

Completed

Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)

Rhinitis, Allergic, Seasonal

United States
Idorsia Pharmaceuticals Ltd.

Completed

Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis (SAR)

Seasonal Allergic Rhinitis

United States
Kasr El Aini Hospital

Completed

Asymptomatic COVID-19 Infection Among Healthcare Workers

Immunologic Activity Alteration

Egypt
UCB Pharma

Completed

POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)

Seasonal Allergic Rhinitis
AstraZeneca

Completed

Study Using the Environmental Exposure Chamber (EEC) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in Treatment of Seasonal Allergic Rhinitis (BY9010/M1-406)

Rhinitis, Allergic, Seasonal | Hay Fever

Canada
AstraZeneca

Completed

To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401)

Rhinitis, Allergic, Seasonal | Hay Fever

United States
Istituto Clinico Humanitas

Recruiting

Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV.

Covid19

Italy
GlaxoSmithKline

Completed

A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage.

Sinusitis | Seasonal Allergic Rhinitis

United Kingdom
Kern Medical Center

Completed

Social Determinants of Health in Patients With Penetrating Trauma Injuries Before and During the COVID-19 Pandemic

COVID-19 | Social Determinants of Health | Penetrating Injury

United States
Johnson & Johnson Consumer and Personal Products...
Pfizer

Completed

Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)

Allergic Rhinitis | Rhinitis, Allergic, Seasonal | Hay Fever | SAR
AstraZeneca

Completed

Study Using the Environmental Exposure Unit (EEU) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-407)

Rhinitis, Allergic, Seasonal | Hay Fever

Canada
AstraZeneca

Completed

A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413)

Rhinitis, Allergic, Seasonal | Hay Fever

Canada
Soliton
Emergent Clinical Consulting, LLC

Completed

Proof of Concept (POC) Study of the Soliton's Acoustic Scar Reduction (ASR) Treatment for the Treatment of Keloid Scar (ASR)

Keloid Scar

United States
M.D. Anderson Cancer Center

Terminated

SAR439459 and Cemiplimab for the Treatment of Advanced or Unresectable Solid Tumors, Strategic Alliance, TACTIC TRIAL

Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm

United States
Antigen Laboratories, Inc.

Withdrawn

Phase 2 Study in Adults Sensitized to Short Ragweed

Allergic Rhinitis
Zheng Liu ENT

Recruiting

A Study of IL4Rα Monoclonal Antibody in Patients With Uncontrolled Seasonal Allergic Rhinitis.

Allergic Rhinitis

China
Dynavax Technologies Corporation

Completed

An Evaluation of the Efficacy and Safety of TOLAMBA™ for Ragweed-Allergic Rhinitis in an Environmental Exposure Chamber

Rhinitis, Allergic, Seasonal

Canada
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)

Seasonal Allergic Rhinitis | Hay Fever

United States
Shanghai PerHum Therapeutics Co., Ltd.
Shanghai Zhongshan Hospital

Recruiting

CCT301-38 CAR-T in Patients With Relapsed or Refractory AXL Positive Sarcomas

SAR

China
Aura Biosciences

Terminated

Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM) (IL)

Choroidal Melanoma | Indeterminate Lesions

United States
Fundación Pública Andaluza para la gestión de la...

Completed

Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19) (COVIMAR)

Virus Diseases

Spain
Critical Biologics Corporation

Completed

Ascending Single Dose Study of Rhu-pGelsolin in Patients With Decreased Gelsolin Levels

Burns | Trauma | Infection | Low Gelsolin

Hong Kong
Faes Farma, S.A.
Allied Research International

Completed

PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-arm)

Seasonal Allergic Rhinitis | Hay Fever | Rhinoconjunctivitis

Canada
Bausch & Lomb Incorporated

Completed

Bepotastine Besilate Nasal Sprays in the Treatment of Seasonal Allergic Rhinitis (SAR)

Seasonal Allergic Rhinitis

United States
Glenmark Specialty S.A.

Completed

Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR) (GSP 301-305)

Seasonal Allergic Rhinitis (SAR)

United States
Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR).

Allergic Rhinitis
Chinese University of Hong Kong

Not yet recruiting

Degenerative Achilles Tendon Rupture Repair With Regeneten Augmentation

Achilles Tendinopathy | Achilles Tendon Rupture

Hong Kong
Dynavax Technologies Corporation

Terminated

Efficacy and Safety Study of TOLAMBA™ in Ragweed-Allergic Adults

Rhinitis, Allergic, Seasonal

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System

CAD

United States
Chinese University of Hong Kong

Completed

Comprehensive Risk Assessment of People With Silicosis: A Population-based Study

Silicosis

China
The University of Hong Kong

Completed

Effectiveness of an Adventure-based Training Programme to Reduce Fatigue for Childhood Cancer Survivors

Childhood Cancer

China

3

Subscribe